T Cells Engineered with a Cytomegalovirus-Specific Chimeric Immunoreceptor

Cytomegalovirus (CMV) infection in patients receiving hematopoietic stem cell transplants (HSCT) is associated with morbidity and mortality. Adoptive T cell immunotherapy has been used to treat viral reactivation but is hardly feasible in high-risk constellations of CMV-positive HSCT patients and CM...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Full, Florian, Lehner, Manfred, Thonn, Veronika, Goetz, Gabriel, Scholz, Brigitte, Kaufmann, Kerstin B., Mach, Michael, Abken, Hinrich, Holter, Wolfgang, Ensser, Armin
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2010
Soggetti:
Vaccines and Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2849495/
https://ncbi.nlm.nih.gov/pubmed/20147393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02117-09
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi